Chandra P. Leo

750 total citations
15 papers, 615 citations indexed

About

Chandra P. Leo is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Chandra P. Leo has authored 15 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Cancer Research. Recurrent topics in Chandra P. Leo's work include Cell death mechanisms and regulation (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Chandra P. Leo is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Chandra P. Leo collaborates with scholars based in United States, Germany and Switzerland. Chandra P. Leo's co-authors include Aaron J.W. Hsueh, Sheau Yu Hsu, Jeehyeon Bae, Margareta D. Pisarska, Cornelia Leo, Thomas D. Szucs, Michael Wiederholt, Claus Garbe, S. Berweck and A. Lepple-Wienhues and has published in prestigious journals such as Journal of Biological Chemistry, Endocrine Reviews and Nature Reviews Drug Discovery.

In The Last Decade

Chandra P. Leo

15 papers receiving 605 citations

Peers

Chandra P. Leo
Suzanne B.R. Jacobs United States
Kimi S. Hatton United States
Lisa K. Mullany United States
María May Argentina
Suzanne D. Westfall United States
Linah Al-Alem United States
Kalpit Shah United States
Suzanne B.R. Jacobs United States
Chandra P. Leo
Citations per year, relative to Chandra P. Leo Chandra P. Leo (= 1×) peers Suzanne B.R. Jacobs

Countries citing papers authored by Chandra P. Leo

Since Specialization
Citations

This map shows the geographic impact of Chandra P. Leo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandra P. Leo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandra P. Leo more than expected).

Fields of papers citing papers by Chandra P. Leo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandra P. Leo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandra P. Leo. The network helps show where Chandra P. Leo may publish in the future.

Co-authorship network of co-authors of Chandra P. Leo

This figure shows the co-authorship network connecting the top 25 collaborators of Chandra P. Leo. A scholar is included among the top collaborators of Chandra P. Leo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandra P. Leo. Chandra P. Leo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Leo, Chandra P., Cornelia Leo, & Thomas D. Szucs. (2020). Publisher Correction: Breast cancer drug approvals by the US FDA from 1949 to 2018. Nature Reviews Drug Discovery. 19(4). 291–291. 3 indexed citations
2.
Leo, Chandra P., Bettina Hentschel, Thomas D. Szucs, & Cornelia Leo. (2020). FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis. Cancers. 12(2). 437–437. 22 indexed citations
3.
Leo, Chandra P., Cornelia Leo, & Thomas D. Szucs. (2019). Breast cancer drug approvals by the US FDA from 1949 to 2018. Nature Reviews Drug Discovery. 19(1). 11–11. 30 indexed citations
4.
Leo, Cornelia, Lars‐Christian Horn, Bettina Hentschel, et al.. (2007). Lack of Apoptotic Protease Activating Factor-1 Expression and Resistance to Hypoxia-Induced Apoptosis in Cervical Cancer. Clinical Cancer Research. 13(4). 1149–1153. 7 indexed citations
5.
Leo, Chandra P., Lars‐Christian Horn, & Michael Höckel. (2006). Hypoxia and expression of the proapoptotic regulator BNIP3 in cervical cancer. International Journal of Gynecological Cancer. 16(3). 1314–1320. 24 indexed citations
6.
Raida, Martin Kristian, Chandra P. Leo, Dominik Lenz, et al.. (2006). Circulating endothelial progenitor cells are inversely correlated with the median oxygen tension in the tumor tissue of patients with cervical cancer. Oncology Reports. 16(3). 597–601. 5 indexed citations
7.
Stepan, Holger, et al.. (2004). Localization and expression of the pro-apoptotic “cell death” factor BNIP3 in placentas from hypertensive pregnancies Titel. Pathology - Research and Practice. 200(4). 329–329. 1 indexed citations
8.
Leo, Chandra P., Sheau Yu Hsu, & Aaron J.W. Hsueh. (2002). Hormonal Genomics. Endocrine Reviews. 23(3). 369–381. 9 indexed citations
9.
Bae, Jeehyeon, et al.. (2001). Underphosphorylated BAD interacts with diverse antiapoptotic Bcl-2 family proteins to regulate apoptosis. APOPTOSIS. 6(5). 319–330. 44 indexed citations
10.
Leo, Chandra P., Margareta D. Pisarska, & Aaron J.W. Hsueh. (2001). DNA Array Analysis of Changes in Preovulatory Gene Expression in the Rat Ovary1. Biology of Reproduction. 65(1). 269–276. 64 indexed citations
11.
Leo, Chandra P., Ursula A. Vitt, & Aaron J.W. Hsueh. (2000). The Ovarian Kaleidoscope Database: An Online Resource for the Ovarian Research Community*. Endocrinology. 141(9). 3052–3054. 25 indexed citations
12.
Bae, Jeehyeon, Chandra P. Leo, Sheau Yu Hsu, & Aaron J.W. Hsueh. (2000). MCL-1S, a Splicing Variant of the Antiapoptotic BCL-2 Family Member MCL-1, Encodes a Proapoptotic Protein Possessing Only the BH3 Domain. Journal of Biological Chemistry. 275(33). 25255–25261. 244 indexed citations
15.
Lepple-Wienhues, A., et al.. (1996). K + Channels and the Intracellular Calcium Signal in Human Melanoma Cell Proliferation. The Journal of Membrane Biology. 151(2). 149–157. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026